Yuhao He
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuhao He has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Huanhuan Cui
Shenzhen Key Laboratory of Gene Regulation and Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China
17 shared publications - Jiao Yang
Shenzhen Key Laboratory of Gene Regulation and Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, Guangdong, P.R. China
17 shared publications - Jun Li
Shenzhen Key Laboratory of Gene Regulation and Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, Guangdong, P.R. China
17 shared publications - Ke Fang
Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, China
17 shared publications - Li Zhang
Shenzhen Key Laboratory of Gene Regulation and Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, Guangdong, P.R. China
17 shared publications - Liang Fang
Shenzhen Key Laboratory of Gene Regulation and Systems Biology, School of Life Sciences, Southern University of Science and Technology
17 shared publications
Latest Publications
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Table S1 from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Table S1. The list of oligos used in the study
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Table S1. The list of oligos used in the study
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Table S2 from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Table S2. The list and sequences of gRNAs
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Table S2. The list and sequences of gRNAs
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Table S5 from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Table S5. The list of peaks and genes enriched in DDX6-eCLIP-seq
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Table S5. The list of peaks and genes enriched in DDX6-eCLIP-seq
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Table S2 from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Table S2. The list and sequences of gRNAs
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Table S2. The list and sequences of gRNAs
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Table S6 from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Table S6. The list of differentially expressed proteins upon DDX6 or EDC4 knockout
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Table S6. The list of differentially expressed proteins upon DDX6 or EDC4 knockout
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Data from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Epithelial–mesenchymal transition (EMT) is a fundamental cellular process frequently hijacked by cancer cells to promote tumor progression, especially metastasis. EMT is orchestrated by a complex molecular network acting at different layers of gene regulation. In addition to transcriptional regulation, posttranscriptional mechanisms may also play a role in EMT. Here, we performed a pooled CRISPR screen analyzing the influence of 1,547 RNA-binding proteins on cell motility in colon cancer cells and identified multiple core components of P-bodies (PB) as negative modulators of cancer cell migration. Further experiments demonstrated that PB depletion by silencing DDX6 or EDC4 could activate hallmarks of EMT thereby enhancing cell migration in vitro as well as metastasis formation in vivo. Integrative multiomics analysis revealed that PBs could repress the translation of the EMT driver gene HMGA2, which contributed to PB-meditated regulation of EMT. This mechanism is conserved in other cancer types. Furthermore, endoplasmic reticulum stress was an intrinsic signal that induced PB disassembly and translational derepression of HMGA2. Taken together, this study has identified a function of PBs in the regulation of EMT in cancer.Significance:Systematic investigation of the influence of posttranscriptional regulation on cancer cell motility established a connection between P-body–mediated translational control and EMT, which could be therapeutically exploited to attenuate metastasis formation.
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Epithelial–mesenchymal transition (EMT) is a fundamental cellular process frequently hijacked by cancer cells to promote tumor progression, especially metastasis. EMT is orchestrated by a complex molecular network acting at different layers of gene regulation. In addition to transcriptional regulation, posttranscriptional mechanisms may also play a role in EMT. Here, we performed a pooled CRISPR screen analyzing the influence of 1,547 RNA-binding proteins on cell motility in colon cancer cells and identified multiple core components of P-bodies (PB) as negative modulators of cancer cell migration. Further experiments demonstrated that PB depletion by silencing DDX6 or EDC4 could activate hallmarks of EMT thereby enhancing cell migration in vitro as well as metastasis formation in vivo. Integrative multiomics analysis revealed that PBs could repress the translation of the EMT driver gene HMGA2, which contributed to PB-meditated regulation of EMT. This mechanism is conserved in other cancer types. Furthermore, endoplasmic reticulum stress was an intrinsic signal that induced PB disassembly and translational derepression of HMGA2. Taken together, this study has identified a function of PBs in the regulation of EMT in cancer.Significance:Systematic investigation of the influence of posttranscriptional regulation on cancer cell motility established a connection between P-body–mediated translational control and EMT, which could be therapeutically exploited to attenuate metastasis formation.
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Table S6 from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Table S6. The list of differentially expressed proteins upon DDX6 or EDC4 knockout
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Table S6. The list of differentially expressed proteins upon DDX6 or EDC4 knockout
- Open Access
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Table S5 from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Table S5. The list of peaks and genes enriched in DDX6-eCLIP-seq
- 4 March 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition
Table S5. The list of peaks and genes enriched in DDX6-eCLIP-seq